It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Senior Research Site PartnershipManager,you willsupport the execution of enterprise research strategies through strong relationship management and site-level engagement. The Senior Manager partners closely with assigned oncology research sites to enhance performance, support enrollment growth, and ensure alignment with organizational priorities whileoperatingeffectively within a matrixed environment. In this role you will:
Serve as a primary relationship manager for a portfolio of oncology researchsites.
Support site engagement, alignment, and performance with a focus on clinical trial enrollmentgrowth.
Execute strategic account plans andbringforward site-levelinsights.
Partner with site leaders to address challenges and support operationalsuccess.
Collaborate across teams to implement enterpriseinitiatives.
Manages a portfolio ofapproximately 2–4 oncology research sites, depending oncomplexity.
Maintain an understanding of each site’s structure, goals, andopportunities.
Support alignment of enterprise initiatives with siteneeds.
Support accountability for clinical trial enrollmentperformance.
Monitor enrollment trends andidentifyimprovementopportunities.
Assistin development and tracking of site-level actionplans.
Promote best practices that supportaccrual.
Partner with sites to review, track, andreportkey performance indicators (KPIs) and support performance improvementefforts.
Support implementation of enterprise priorities at the sitelevel.
Assistsites through change initiatives and workflowtransitions.
Escalate trends, risks, and opportunitiestoleadership.
Identifyand support resolution of operational challenges at the sitelevel.
Escalate complex or high-impact issuesappropriately.
Identifyopportunities to improve processes andengagement.
You should have for this position:
A bachelor’s degree,master’sdegree preferred
Experience supporting oncology research sites and clinical trialenrollment.
Experience in site engagement, account management, or clinical operations
Knowledge of clinical research operations and site-level execution
Understanding of oncology clinical trials and enrollment drivers
Familiarity with performance metrics and site engagement strategies
Relationship management and stakeholder engagement
Data interpretation and performance monitoring
Communication and facilitation across cross-functional teams
Problem-solving and issue resolution
Ability tooperateeffectively in a matrixedenvironment.
Ability to manage multiple site relationshipssimultaneously.
Ability to influence without directauthority.
Ability to translate strategic priorities into site-levelexecution.
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
McKesson has become aware of online recruiting-related scams in which individuals who are not affiliated with or authorized by McKesson are using McKesson’s (or affiliated entities, like CoverMyMeds or RxCrossroads) name in fraudulent emails, job postings or social media messages. In light of these scams, please bear the following in mind:
McKesson Talent Advisors will never solicit money or credit card information in connection with a McKesson job application.
McKesson Talent Advisors do not communicate with candidates via online chatrooms or using email accounts such as Gmail or Hotmail. Note that McKesson does rely on a virtual assistant (Gia) for certain recruiting-related communications with candidates.
McKesson job postings are posted on our career site: careers.mckesson.com
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations, conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at over 200 locations in more than 20 states across the U.S.
